Literature DB >> 116727

The influence of calcitonin on the plasma and urine phosphate changes produced by parathyroid hormone.

R V Talmage, C J VanderWiel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 116727     DOI： 10.1007/bf02441229

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN： 0171-967X            Impact factor:   4.333


× No keyword cloud information.
  16 in total

1.  THYROCALCITONIN: HYPOCALCEMIC HYPOPHOSPHATEMIC PRINCIPLE OF THE THYROID GLAND.

Authors:  P F HIRSCH; E F VOELKEL; P L MUNSON
Journal:  Science       Date:  1964-10-16       Impact factor: 47.728

2.  THYROID HYPOCALCEMIC PRINCIPLE AND RECURRENT LARYNGEAL NERVE INJURY AS FACTORS AFFECTING THE RESPONSE TO PARATHYROIDECTOMY IN RATS.

Authors:  P F HIRSCH; G F GAUTHIER; P L MUNSON
Journal:  Endocrinology       Date:  1963-08       Impact factor: 4.736

3.  Observations on the relationship of parathyroid hormone and calcitonin to plasma and liver phosphate.

Authors:  R V Talmage; S H Doppelt; J H Postma
Journal:  Proc Soc Exp Biol Med       Date:  1976-10

4.  Effect of calcitonin and calcium infusion on plasma phosphate.

Authors:  R V Talmage; L A Whitehurst; J J Anderson
Journal:  Endocrinology       Date:  1973-03       Impact factor: 4.736

5.  The effect of calcitonin on 32 P disappearance from plasma in parathyroidectomized and nephrectomized rats.

Authors:  R V Talmage; J J Anderson
Journal:  Proc Soc Exp Biol Med       Date:  1972-12

6.  Microdetermination of calcium in biological material by automatic fluorometric titration.

Authors:  A B Borle; F N Briggs
Journal:  Anal Chem       Date:  1968-02       Impact factor: 6.986

7.  Effect of salmon calcitonin infusion on plasma concentrations of recently administered 45Ca.

Authors:  S A Grubb; T C Markham; R V Talmage
Journal:  Calcif Tissue Res       Date:  1977-12-29

8.  Thyrocalcitonin inhibition of bone resorption induced by parathyroid extract in thyroparathyroidectomized rats.

Authors:  P F Hirsch
Journal:  Endocrinology       Date:  1967-03       Impact factor: 4.736

9.  An inhibitory effect of thyrocalcitonin on calcium release in vivo and on bone metabolism in vitro.

Authors:  C C Johnston; W P Deiss
Journal:  Endocrinology       Date:  1966-06       Impact factor: 4.736

10.  Electron microscopic study of the effects of calcitonin on bone cells and their extracellular milieu.

Authors:  H Norimatsu; C J Wiel; R V Talmage
Journal:  Clin Orthop Relat Res       Date:  1979 Mar-Apr       Impact factor: 4.176
View more
  7 in total

1.  A study of the action of calcitonin by its effects on lead-induced hypercalcemia.

Authors:  R V Talmage; C J VanderWiel
Journal:  Calcif Tissue Int       Date:  1979       Impact factor: 4.333

2.  Calcium homeostasis. III: The bone membrane potential and mineral dissolution.

Authors:  K J McGrath; W J Heideger; K W Beach
Journal:  Calcif Tissue Int       Date:  1986-10       Impact factor: 4.333

3.  Calcium homeostasis. II: The sodium-potassium pump.

Authors:  D J Wirth; W J Heideger; K W Beach
Journal:  Calcif Tissue Int       Date:  1986-05       Impact factor: 4.333

4.  Reduction of lead-induced hypercalcemia by calcitonin: comparison between thyroid-intact and thyroidectomized rats.

Authors:  R V Talmage; C J VanderWiel
Journal:  Calcif Tissue Int       Date:  1982-01       Impact factor: 4.333

5.  Evidence for an important physiological role for calcitonin.

Authors:  R V Talmage; S A Grubb; H Norimatsu; C J Vanderwiel
Journal:  Proc Natl Acad Sci U S A       Date:  1980-01       Impact factor: 11.205

6.  Calcium homeostasis: the effect of parathyroid hormone on bone membrane electrical potential difference.

Authors:  D R Peterson; W J Heideger; K W Beach
Journal:  Calcif Tissue Int       Date:  1985-05       Impact factor: 4.333

7.  Long-term effects of high or low Ca intakes and of lack of parathyroid function on rat femur biomechanics.

Authors:  J L Ferretti; R D Tessaro; E O Audisio; C D Galassi
Journal:  Calcif Tissue Int       Date:  1985-12       Impact factor: 4.333
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.